Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Echeverria

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Frontiers in Pharmacology|October 23, 2012
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco ConsumptionValentina Echeverria Moran
CNS & Neurological Disorders Drug Targets|March 6, 2010
Raf inhibitors as therapeutic agents against neurodegenerative diseasesSarah Burgess, Valentina Echeverria
CNS Neuroscience & Therapeutics|April 26, 2012
Cotinine: a potential new therapeutic agent against Alzheimer's diseaseValentina Echeverria, Ross Zeitlin
Neurochemical Research|June 28, 2014
New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from NicotineJ Alex Grizzell, Valentina Echeverria
Molecular Neurobiology|November 14, 2002
Intracellular A-beta amyloid, a sign for worse things to come?Valentina Echeverria, A Claudio Cuello
Cancer Chemotherapy and Pharmacology|October 7, 2016
Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in ratsAlexandre Iarkov, Doreen Appunn, Valentina Echeverria
The European Journal of Neuroscience|November 3, 2005
Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposureValentina Echeverria, Andrew Clerman, Sylvain Doré
Progress in Neurobiology|January 23, 2016
Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's diseaseValentina Echeverria, Alex Yarkov, Gjumrakch Aliev
Frontiers in Neuroscience|October 7, 2021
Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson's DiseaseAlexandre Iarkov, Cristhian Mendoza, Valentina Echeverria
Frontiers in Neuroscience|May 31, 2023
Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseasesValentina Echeverria, Cristhian Mendoza, Alex Iarkov
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|October 23, 2012
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco ConsumptionValentina Echeverria Moran
CNS & Neurological Disorders Drug Targets|March 6, 2010
Raf inhibitors as therapeutic agents against neurodegenerative diseasesSarah Burgess, Valentina Echeverria
CNS Neuroscience & Therapeutics|April 26, 2012
Cotinine: a potential new therapeutic agent against Alzheimer's diseaseValentina Echeverria, Ross Zeitlin
Neurochemical Research|June 28, 2014
New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from NicotineJ Alex Grizzell, Valentina Echeverria
Molecular Neurobiology|November 14, 2002
Intracellular A-beta amyloid, a sign for worse things to come?Valentina Echeverria, A Claudio Cuello
Cancer Chemotherapy and Pharmacology|October 7, 2016
Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in ratsAlexandre Iarkov, Doreen Appunn, Valentina Echeverria
The European Journal of Neuroscience|November 3, 2005
Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposureValentina Echeverria, Andrew Clerman, Sylvain Doré
Progress in Neurobiology|January 23, 2016
Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's diseaseValentina Echeverria, Alex Yarkov, Gjumrakch Aliev
Frontiers in Neuroscience|October 7, 2021
Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson's DiseaseAlexandre Iarkov, Cristhian Mendoza, Valentina Echeverria
Frontiers in Neuroscience|May 31, 2023
Nicotinic acetylcholine receptors and learning and memory deficits in Neuroinflammatory diseasesValentina Echeverria, Cristhian Mendoza, Alex Iarkov
Pageof 9